3,5-Difluoromethcathinone
3,5-Difluoromethcathinone (also known as 3,5-DFMC) is a chemical compound from the cathinone family that has been sold as a designer drug, first being identified in Australia in 2009.[1]
![]() | |
| Clinical data | |
|---|---|
| Other names | 3-DFMC, 3,5-Difluoromethcathinone |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C10H11F2NO |
| Molar mass | 199.201 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Legal status
In the United Kingdom, 3,5-DFMC is a controlled drug under the cathinone blanket ban.
3,5-DFMC is an Anlage II controlled drug in Germany.
See also
References
- Davis S, Rands-Trevor K, Boyd S, Edirisinghe M (April 2012). "The characterisation of two halogenated cathinone analogues: 3,5-difluoromethcathinone and 3,5-dichloromethcathinone". Forensic Science International. 217 (1–3): 139–45. doi:10.1016/j.forsciint.2011.10.042. PMID 22088945.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
